HighVista Strategies’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,226
Closed -$345K 132
2021
Q1
$345K Sell
10,226
-5,164
-34% -$184K 0.26% 74
2020
Q4
$537K Buy
15,390
+1,190
+8% +$41.1K 0.34% 66
2020
Q3
$493K Sell
14,200
-600
-4% -$20K 0.36% 50
2020
Q2
$485K Sell
14,800
-3,800
-20% -$121K 0.4% 27
2020
Q1
$560K Sell
18,600
-35,200
-65% -$1.05M 0.52% 20
2019
Q4
$1.56M Sell
53,800
-23,000
-30% -$637K 1.18% 25
2019
Q3
$1.99M Buy
76,800
+7,800
+11% +$197K 1.35% 25
2019
Q2
$1.76M Sell
69,000
-5,800
-8% -$143K 0.9% 26
2019
Q1
$1.96M Sell
74,800
-10,200
-12% -$251K 1.6% 24
2018
Q4
$1.96M Sell
85,000
-24,200
-22% -$538K 1.69% 19
2018
Q3
$2.57M Buy
109,200
+9,600
+10% +$234K 1.2% 22
2018
Q2
$2.3M Buy
99,600
+34,200
+52% +$813K 1.04% 23
2018
Q1
$1.61M Buy
65,400
+2,600
+4% +$68.3K 0.69% 25
2017
Q4
$1.69M Buy
+62,800
New +$1.6M 0.47% 50
2015
Q4
Sell
-115,234
Closed -$3.13M 223
2015
Q3
$3.13M Sell
115,234
-11,318
-9% -$320K 0.59% 83
2015
Q2
$3.46M Sell
126,552
-30,892
-20% -$868K 0.59% 80
2015
Q1
$4.2M Buy
+157,444
New +$3.63M 0.67% 72

Other funds holding NVO

HighVista Strategies's NVO Position: Q2 2021 in Review

HighVista Strategies sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 10,226 shares — an estimated $345K sold.

HighVista Strategies first reported a position in NVO in Q1 2015 and held it in 17 quarters. The position peaked at $4.2M in Q1 2015. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • HighVista Strategies reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • HighVista Strategies sold 10,226 Novo Nordisk shares in Q2 2021, an estimated $345K.
  • HighVista Strategies first reported a position in Novo Nordisk in Q1 2015 and held it in 17 quarters.
  • HighVista Strategies's Novo Nordisk position peaked at $4.2M in Q1 2015.
  • 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.